Graphic method for reporting risk to a patient
AssigneeVivigen, Inc.
InventorKyrieckos A. Aleck
Life of this patent
Estimating the term…
Abstract
A graph comprising a distribution curve for displaying a distribution of test results for given population and a density gradient superimposed over the distribution curve for displaying and probability of an event or condition occurring for each such test result in the distribution. Typically the distribution curve is plotted against a cartesian coordinate system. The density gradient is superimposed below the distribution curve and shows the increasing risk of a condition as a function of a test result by an increase in density of the gradient with increasing risk. A marker imposed on the distribution curve shows the test result for a specific individual.
Claims6
A method of displaying the results of testing maternal blood serum of a patient for alphafetoprotein level, the method comprising the steps of:
- representing on a surface in Cartesian coordinates a distribution curve of alphafetoprotein levels in maternal blood serum for a population of patients such that the distribution curve represents the number of expectant mothers on the vertical axis and the alphafetoprotein level on the horizontal axis;
- representing on the surface a gradually increasing risk of Down Syndrome with decreasing alphafetoprotein levels along the horizontal axis;
- and
- placing on the surface a mark representing the alphafetoprotein level of the patient being tested, and thus the risk of Down Syndrome to the patient by the representation of risk along the horizontal axis at the mark.
A method of displaying the results of testing material blood serum of a patient for alphafetoprotein level, the method comprising the steps of:
- representing on a surface in cartesian coordinates a distribution curve of alphafetoprotein levels in maternal blood serum for a population of patients such that the distribution curve represents the number of expectant mothers on the vertical axis and the alphafetoprotein level on the horizontal axis;
- representing on the surface a gradually increasing risk of Open Spina Bifida with increasing alphafetoprotein levels along the horizontal axis;
- and
- placing on the surface a mark representing the alphafetoprotein level of the patient being tested, and thus the risk of Open Spina Bifida to the patient by the representation of risk along the horizontal axis at the mark.
Dependencies are inferred from the claim text.